Loading...
Docoh

Inari Medical (NARI)

Employees
Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
The annual meeting of shareholders of Inari Medical, Inc. (the “Company”) was held on May 26, 2022. The final voting results for each proposal are set forth below.

1.Each of the following Class II director nominees was elected to serve on the Company’s board of directors for a three-year term expiring at the Company’s 2025 annual meeting of shareholders, by the following vote:


Name of Nominee

Votes For
Votes Withheld
Broker Non-Votes
Dona G. Mead, Jr. 35,959,814 5,509,355 6,877,298
Kirk Nielsen 30,381,282 11,083,496 6,881,689
Catherine Szyman 32,369,734 9,095,044 6,881,689

2.The shareholders ratified the selection of BDO USA, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022. The votes regarding this proposal were as follows:

Votes For Votes Against Abstentions Broker Non-Votes
48,308,481 12,315 25,671 0

3.The shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in our proxy statement. The votes regarding this proposal were as follows:

Votes For Votes Against Abstentions Broker Non-Votes
36,070,016 5,283,156 115,997 6,877,298

4.The shareholders approved the advisory vote on the frequency of future advisory votes on executive compensation to be held every one year. The votes regarding this proposal were as follows:

Votes For 1 yr. Votes For 2 yr. Votes For 3 yr. Abstentions Broker Non-Votes
38,537,361 74,627 2,810,605 46,575 6,877,298

No other matters were submitted for shareholder action.